Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine Dosing for Perioperative Pain in ERAS
NCT06431165Phase 2Recruiting
- Sponsor
- Cairo University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in perioperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Total Intraoperative opioid consumption (Fentanyl). Started Mar 2024; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on NCT06431165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431165.